Evidence map›Paper›PMID 27235509›Full record

ArticleOncotarget2016

Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.

Terkild Brink Buus, Jonas Damgård Schmidt, Charlotte Menné Bonefeld, Carsten Geisler, Jens Peter Holst Lauritsen

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The ICOS-ICOSL pathway tunes thymic selection.Immunology and cell biology · 2022
    Article
  5. Review
  6. Impaired Differentiation of Highly Proliferative ICOSInternational journal of molecular sciences · 2021
    Article
  7. Review
  8. Adjustments of γδ T Cells in the Lung ofFrontiers in immunology · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Terkild Brink BuusDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jonas Damgård SchmidtDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Charlotte Menné BonefeldDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Carsten GeislerDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jens Peter Holst LauritsenDepartment of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-stimulation is an integral part of T cell signaling involved in almost all facets of T cell biology. While much is known about co-stimulation in differentiation and function of conventional αβ T cells, less is known about how co-stimulation affects the development and programming of γδ T cells. In this study, we have investigated the role of inducible T cell co-stimulator (ICOS) on the development of γδ T cells. We show that ICOS is expressed by a population of immature Vγ2+CD45RBlow γδ T cells predisposed to interleukin-17 (IL-17) production. We found that treatment with ICOS specific antibodies drastically reduces fetal development of IL-17-producing γδ T cells by agonistic actions, and that ICOS deficient mice have a significant increase in the population of IL-17-producing Vγ2+ γδ T cells in the thymus, spleen, lymph nodes and skin and exhibit exacerbated sensitization responses to 2,4-dinitrofluorobenzene. In conclusion, this study demonstrates that development of IL-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.

Indexed as

AnimalsDinitrofluorobenzeneFlow CytometryInducible T-Cell Co-Stimulator ProteinInterleukin-17Lymph NodesMice, Inbred C57BLMice, KnockoutReceptors, Antigen, T-Cell, gamma-deltaSignal TransductionSkinSpleenThymocytesThymus GlandT-Lymphocyte SubsetsDinitrofluorobenzeneIcos protein, mouseInducible T-Cell Co-Stimulator ProteinInterleukin-17Receptors, Antigen, T-Cell, gamma-deltadevelopmentICOSImmune responseImmunityImmunology and Microbiology Sectioninterleukin-17thymusγδ T cell

Identifiers

PMID27235509
PMCPMC4991387
OpenAlexW2327113690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.